These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1606 related items for PubMed ID: 16873678

  • 1. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [Abstract] [Full Text] [Related]

  • 2. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
    Iizuka K, Miller B, Uyeda K.
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
    [Abstract] [Full Text] [Related]

  • 3. Role of ChREBP in hepatic steatosis and insulin resistance.
    Denechaud PD, Dentin R, Girard J, Postic C.
    FEBS Lett; 2008 Jan 09; 582(1):68-73. PubMed ID: 17716660
    [Abstract] [Full Text] [Related]

  • 4. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 09; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 5. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B, Reitman ML, Gonzalez FJ.
    J Clin Invest; 2003 Mar 09; 111(5):737-47. PubMed ID: 12618528
    [Abstract] [Full Text] [Related]

  • 6. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
    Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H.
    Hepatology; 2003 Dec 09; 38(6):1529-39. PubMed ID: 14647064
    [Abstract] [Full Text] [Related]

  • 7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 09; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 8. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N, Qi Y, Patel HR, Ahima RS.
    J Hepatol; 2004 Sep 09; 41(3):391-8. PubMed ID: 15336441
    [Abstract] [Full Text] [Related]

  • 9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 09; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

  • 10. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q, Jiang L, Wang J, Li S, Yu Y, You J, Zeng R, Gao X, Rui L, Li W, Liu Y.
    Hepatology; 2009 Apr 09; 49(4):1166-75. PubMed ID: 19177596
    [Abstract] [Full Text] [Related]

  • 11. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P, Foufelle F.
    Diabetes Obes Metab; 2010 Oct 09; 12 Suppl 2():83-92. PubMed ID: 21029304
    [Abstract] [Full Text] [Related]

  • 12. ChREBP, a transcriptional regulator of glucose and lipid metabolism.
    Postic C, Dentin R, Denechaud PD, Girard J.
    Annu Rev Nutr; 2007 Oct 09; 27():179-92. PubMed ID: 17428181
    [Abstract] [Full Text] [Related]

  • 13. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K, Lettéron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B.
    Am J Physiol Endocrinol Metab; 2008 May 09; 294(5):E939-51. PubMed ID: 18349116
    [Abstract] [Full Text] [Related]

  • 14. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
    Kaidanovich-Beilin O, Eldar-Finkelman H.
    J Pharmacol Exp Ther; 2006 Jan 09; 316(1):17-24. PubMed ID: 16169938
    [Abstract] [Full Text] [Related]

  • 15. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.
    Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Lettéron P, Fromenty B.
    Obesity (Silver Spring); 2008 Sep 09; 16(9):2053-67. PubMed ID: 19186330
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance and steatosis in humans.
    Capeau J.
    Diabetes Metab; 2008 Dec 09; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [Abstract] [Full Text] [Related]

  • 17. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, Kelly S, Chen S, McKay R, Monia BP, Bhanot S.
    Hepatology; 2005 Aug 09; 42(2):362-71. PubMed ID: 16001399
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
    Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, Yoon JW, Jun HS.
    Diabetes; 2007 Jun 09; 56(6):1671-9. PubMed ID: 17369525
    [Abstract] [Full Text] [Related]

  • 19. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
    van den Hoek AM, Teusink B, Voshol PJ, Havekes LM, Romijn JA, Pijl H.
    J Neuroendocrinol; 2008 Jan 09; 20(1):120-7. PubMed ID: 18081560
    [Abstract] [Full Text] [Related]

  • 20. Increased hepatic lipogenesis in insulin resistance and Type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus.
    Ben Djoudi Ouadda A, Levy E, Ziv E, Lalonde G, Sané AT, Delvin E, Elchebly M.
    Biosci Rep; 2009 Jun 15; 29(5):283-92. PubMed ID: 18842111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.